Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
251 - 300 out of 509Page size: 50
Sort by: 1st author
  1. Published

    Kliniske retningslinjer for behandling af voksne med Type 1 diabetes

    Nørgaard, K., Rossing, Peter, Andersen, H. U., Poulsen, P. L., Winther, Kaj, Pedersen-Bjergaard, Ulrik, Jensen, B. S., Ehlers, G., Rasmussen, A., Nicolaisen, A., Drivsholm, Thomas & Bagger, M., Aug 2010, København: Sundhedsstyrelsen.

    Research output: Book/Report › Report › Communication

  2. Published

    Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study

    Oellgaard, J., Gaede, P., Rossing, Peter, Rorth, R., Køber, Lars Valeur, Parving, H. & Pedersen, Oluf Borbye, 2018, In: Diabetologia. 61, 8, p. 1724-1733

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits

    Oellgaard, J., Gæde, P., Rossing, Peter, Persson, F., Parving, H. & Pedersen, Oluf Borbye, Apr 2017, In: Kidney International. 91, 4, p. 982-988 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer

    Oellgaard, J., Winther, S. A., Hansen, T. S., Rossing, Peter & von Scholten, B. J., 2017, In: Current Pharmaceutical Design. 23, 25, p. 3699-3712

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria

    Oellgaard, J., Gæde, P., Persson, F., Rossing, Peter, Parving, H. & Pedersen, Oluf Borbye, 2018, In: Journal of Diabetes and its Complications. 32, 12, p. 1133-1140

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes

    Ostergaard, J. A., Thiel, S., Hoffmann-Petersen, I. T., Hovind, P., Parving, H., Tarnow, L., Rossing, Peter & Hansen, T. K., 16 Mar 2017, In: Diabetes - Metabolism: Research and Reviews (Print Edition). 33, 5, 6 p., e2895.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy

    Overgaard, A. J., Hansen, H. G., Lajer, M., Pedersen, L., Tarnow, L., Rossing, Peter, McGuire, J. N. & Pociot, Flemming, 2010, In: Proteome Science. 8, p. 4 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The effect of diabetes and the diabetogenic TBC1D4 p.Arg684ter variant on kidney function in Inuit in Greenland

    Overvad, M., Díaz, L. J., Bjerregaard, P., Pedersen, M. L., Larsen, C. V. L., Grarup, Niels, Hansen, Torben, Rossing, Peter & Jørgensen, M. E., 2023, In: International Journal of Circumpolar Health. 82, 8 p., 2191406.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The History of Prevention and Treatment of Diabetic Nephropathy

    Parving, H. H. & Rossing, Peter, 2020, Unveiling Diabetes - Historical Milestones in Diabetology. Karger, Vol. 29. p. 242–256 15 p. (Frontiers in Diabetes, Vol. 29).

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  10. Published

    Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy

    Parving, H. H. & Rossing, Peter, 17 Feb 2015, In: Nature Reviews Nephrology. 11, 2, p. 68-70 3 p.

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy

    Parving, H. H. & Rossing, Peter, 1 Jan 2015, In: Nature Reviews Gastroenterology and Hepatology. 12, 1, p. 47-49 3 p.

    Research output: Contribution to journal › Review › Research › peer-review

  12. Published

    Microalbuminuria: A parameter that has changed diabetes care

    Parving, H. H., Persson, F. & Rossing, Peter, 2015, In: Diabetes Research and Clinical Practice. 107, 1, p. 1-8 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  13. Published

    Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

    Peeters, S. A., Engelen, L., Buijs, J., Jorsal, A., Parving, H., Tarnow, L., Rossing, Peter, Schalkwijk, C. G. & Stehouwer, C. D. A., 26 Apr 2017, In: Cardiovascular Diabetology. 16, 1, 12 p., 55.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes

    Peeters, S. A., Engelen, L., Buijs, J., Theilade, S., Rossing, Peter, Schalkwijk, C. G. & Stehouwer, C. D. A., 2018, In: Journal of Diabetes and its Complications. 32, 3, p. 325-329 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

    Peeters, S. A., Engelen, L., Buijs, J., Chaturvedi, N., Fuller, J. H., Jorsal, A., Parving, H., Tarnow, L., Theilade, S., Rossing, Peter, Schalkwijk, C. G. & Stehouwer, C. D. A., 25 Oct 2017, In: Cardiovascular Diabetology. 16, 9 p., 139.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

    Pena, M. J., Heinzel, A., Rossing, Peter, Parving, H., Dallmann, G., Rossing, K., Andersen, S., Mayer, B. & Heerspink, H. J. L., 5 Jul 2016, In: Journal of Translational Medicine. 14, 203.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes

    Pena, M. J., de Zeeuw, D., Mischak, H., Jankowski, J., Oberbauer, R., Woloszczuk, W., Benner, J., Dallmann, G., Mayer, B., Mayer, G., Rossing, Peter & Lambers Heerspink, H. J., Aug 2015, In: Nephrology, Dialysis, Transplantation. 30, Suppl 4, p. iv86-95

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes

    Pena, M. J., Jankowski, J., Heinze, G., Kohl, M., Heinzel, A., Bakker, S. J. L., Gansevoort, R. T., Rossing, Peter, de Zeeuw, D., Heerspink, H. J. L. & Jankowski, V., Oct 2015, In: Journal of Hypertension. 33, 10, p. 2123-32 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

    Perakakis, N., Bornstein, S. R., Birkenfeld, A. L., Linkermann, A., Demir, M., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L. M., Kolkhof, P., Lawatscheck, R., Scott, C., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2024, In: Diabetes, Obesity and Metabolism. 26, 1, p. 191-200 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES: A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS

    Perkovic, V., Bain, S., Bakris, G., Buse, J., Idorn, T., Mahaffey, K., Marso, S., Nauck, M., Pratley, R., Rasmussen, S., Rossing, Peter, Tornoe, K., Zinman, B. & Mann, J., 2019, In: Nephrology Dialysis Transplantation. 34, Supplement_1, 1 p., SaO010.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  21. Published

    Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Perkovic, V., Agarwal, R., Fioretto, P., Hemmelgarn, B. R., Levin, A., Thomas, M. C., Wanner, C., Kasiske, B. L., Wheeler, D. C., Groop, P. H., Bakris, G. L., Cooper, M. E., Chae, D. W., Davidson, M. H., de Boer, I. H., de Zeeuw, D., Fornoni, A., Gnudi, L., Herzog, C. A., Hung, A. M. & 30 others, Jafar, T. H., Jardine, M., Jha, V., Ji, L., Kahn, S. E., Langham, R. G., Lerma, E. V., Ma, R. C. W., Makino, H., Marre, M., Mauer, M., Metsärinne, K., Nelson, R. G., Pecoits-Filho, R., Pollock, C. A., Rajapurkar, M., Rossing, Peter, Rychlík, I., Sharma, K., Stanton, R. C., Tesař, V., Tikkanen, I., Tomson, C. R. V., Toto, R. D., Tsukamoto, Y., Tuttle, K. R., Wada, T., Williams, W. W., Zhang, H. & Zoungas, S., 1 Dec 2016, In: Kidney International. 90, 6, p. 1175-1183 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER

    Perkovic, V., Bain, S., Bakris, G., Buse, J., Gondolf, T., Idorn, T., Lausvig, N., Mahaffey, K., Marso, S., Nauck, M., Pratley, R., Rossing, Peter, Zinman, B. & Mann, J., 2019, In: Nephrology Dialysis Transplantation. 34, Supplement_1, 1 p., FP482EGFR .

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  23. Published

    EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR): A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER

    Perkovic, V., Bain, S., Bakris, G., Buse, J., Idorn, T., Mahaffey, K., Marso, S., Nauck, M., Pratley, R., Rasmussen, S., Rossing, Peter, Tornoe, K., Zinman, B. & Mann, J., 2019, In: Nephrology Dialysis Transplantation. 34, Supplement_1, 1 p., FP483.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  24. Published

    Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes

    Persson, F., Theilade, S., Eugen-Olsen, J., Rossing, Peter & Parving, H., 2016, In: Journal of Diabetes and its Complications. 30, 8, p. 1440-1442 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    526-P: Dapagliflozin Improves the Urinary CKD273 Proteomic Score When Added to Renin-Angiotensin Blockade in Patients with Type 2 Diabetes and Nephropathy

    Persson, F., Eickhoff, M. K., Mischak, H., Frimodt-moller, M. & Rossing, Peter, 2019, In: Diabetes. 68, Supplement 1, p. 526-P

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  26. Published

    Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Persson, F., Bain, S. C., Mosenzon, O., Heerspink, H. J. L., Mann, J. F. E., Pratley, R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Rossing, Peter & LEADER Trial Investigators, L. T. I., 2021, In: Diabetes Care. 44, 3, 7 p., dc201622.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

    Persson, F., Lindhardt, M., Rossing, Peter & Parving, H., 2016, In: Journal of the Renin-Angiotensin-Aldosterone System. 17, 3, p. 1-10 10 p.

    Research output: Contribution to journal › Review › Research › peer-review

  28. Published

    Individual Effects of Liraglutide on Cardiorenal Risk Markers: Results from the LEADER Trial

    Persson, F., Zobel, E. H., Hansen, T., Rasmussen, S., von Scholten, B. J., Wolthers, B. & Rossing, Peter, 2019, In: Journal of the American Society of Nephrology. 30, Kidney Week Edition, 2 p., PUB071.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  29. Published

    Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

    Persson, F., Rossing, Peter, Vart, P., Chertow, G. M., Hou, F. F., Jongs, N., McMurray, J. J., Correa-Rotter, R., Bajaj, H. S., Stefansson, B., Toto, R. D., Langkilde, A. M., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2021, In: Diabetes Care. 44, 8, p. 1894-1897 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives

    Persson, F. & Rossing, Peter, 2019, In: Proteomics - Clinical Applications. 13, 2, 1800176.

    Research output: Contribution to journal › Review › Research › peer-review

  31. Published

    A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

    Persson, F., Borg, Rikke & Rossing, Peter, 1 Apr 2021, In: Annals of Translational Medicine. 9, 8, p. 716-716 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria

    Persson, F., Rossing, Peter, Reinhard, H., Juhl, T., Stehouwer, C. D. A., Schalkwijk, C., Danser, A. H. J., Boomsma, F., Frandsen, E. & Parving, H., 2009, In: Diabetes Care. 32, 10, p. 1873-9 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

    Persson, F., Frimodt-Møller, M. & Rossing, Peter, 2019, In: Kidney International Reports. 4, 10, p. 1362-1365 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  34. Published

    Diagnosis of diabetic kidney disease: state of the art and future perspective

    Persson, F. & Rossing, Peter, 2018, In: Kidney International Supplements. 8, 1, p. 2-7

    Research output: Contribution to journal › Review › Research › peer-review

  35. Published

    Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetes

    Petersen, E. H., Theilade, S., Hansen, T. W., Lindhardt, M. K. & Rossing, Peter, Dec 2015, In: Blood Pressure Monitoring. 20, 6, p. 369-72 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    Clinical assessment of excretory renal function

    Petersen, L. J., Birn, H., Ladefoged, S. A., Randers, E., Rehling, M., Reinholdt, B. & Rossing, Peter, 2009, In: Ugeskrift for læger. 171, 13, p. 1090 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Klinisk vurdering af ekskretorisk nyrefunktion

    Petersen, L. J., Birn, H., Ladefoged, S. A., Randers, E., Rehling, M., Reinholdt, B. & Rossing, Peter, 2009, In: Ugeskrift for læger. 171, 13, p. 1090

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

    Petrie, J. R., Chaturvedi, N., Ford, I., Hramiak, I., Hughes, A. D., Jenkins, A. J., E Klein, B., Klein, R., Ooi, T. C., Rossing, Peter, Sattar, N., Stehouwer, C. D. A., Colhoun, H. M. & REMOVAL Trial Team, R. T. T., Apr 2017, In: Diabetes, Obesity and Metabolism. 19, 4, p. 509-516 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

    Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, Peter, Stehouwer, C. D. A., Sattar, N., Colhoun, H. M. & REMOVAL Study Group, R. S. G., Aug 2017, In: The Lancet Diabetes & Endocrinology. 5, 8, p. 597-609 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Metformin and cardiorenal outcomes in diabetes: A reappraisal

    Petrie, J. R., Rossing, Peter & Campbell, I. W., 2020, In: Diabetes, Obesity and Metabolism. 22, 6, p. 904-915 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  41. Published

    Variability in response to albuminuria-lowering drugs: true or random?

    Petrykiv, S. I., de Zeeuw, D., Persson, F., Rossing, Peter, Gansevoort, R. T., Laverman, G. D. & Heerspink, H. J. L., Jun 2017, In: British Journal of Clinical Pharmacology. 83, 6, p. 1197-1204 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention

    Petrykiv, S. I., Laverman, G. D., Persson, F., Vogt, L., Rossing, Peter, de Borst, M. H., Gansevoort, R. T., de Zeeuw, D. & Heerspink, H. J. L., 7 Nov 2017, In: Clinical Journal of American Society of Nephrology. . 12, 11, p. 1804-1813 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study

    Piazza, M., Hanssen, N. M. J., Persson, F., Scheijen, J. L., van de Waarenburg, M. P. H., van Greevenbroek, M. M. J., Rossing, Peter, Hovind, P., Stehouwer, C. D. A., Parving, H. H. & Schalkwijk, C. G., 2021, In: Diabetic Medicine. 38, 9, 7 p., e14405.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial

    Pilemann-Lyberg, S., Persson, F., Frystyk, J. & Rossing, Peter, 2018, In: Diabetic Medicine. 35, 3, p. 392-393 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  45. Published

    Serum uric acid and progression of diabetic nephropathy in type 1 diabetes

    Pilemann-Lyberg, S., Lindhardt, M., Persson, F., Andersen, S. & Rossing, Peter, 2018, In: Journal of Diabetes and its Complications. 32, 5, p. 470-473 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes

    Pilemann-Lyberg, S., Hansen, T. W., Persson, F., Theilade, S., Singh Ahluwalia, T., Frystyk, J. & Rossing, Peter, 2019, In: Nephrology, Dialysis, Transplantation. 34, 4, p. 659-666 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes

    Pilemann-Lyberg, S., Hansen, T. W., Tofte, N., Winther, S. A., Theilade, S., Ahluwalia, T. S. & Rossing, Peter, 2019, In: Diabetes Care. 42, 6, p. 1088-1094 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088-1094

    Pilemann-Lyberg, S., Hansen, T. W. & Rossing, Peter, 2019, In: Diabetes Care. 42, 12, p. e188-e188

    Research output: Contribution to journal › Comment/debate › Research

  49. Published

    Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes

    Pilemann-Lyberg, S., Rasmussen, D. G. K., Hansen, T. W., Tofte, N., Winther, S. A., Holm Nielsen, S., Theilade, S., Karsdal, M. A., Genovese, F. & Rossing, Peter, 2019, In: Diabetes Care. 42, 9, p. 1760-1768

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

    Pitt, B., Agarwal, R., Anker, S. D., Ruilope, L. M., Rossing, Peter, Ahlers, C., Brinker, M., Joseph, A., Lambelet, M., Lawatscheck, R. & Filippatos, G. S., 2022, In: JAMA network open. 5, 10, 10 p., E2236123.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...11 Next

ID: 12937790